32. Aronica E, Gorter JA, Ijlst-Keizers H, Rozemuller AJ, Yankaya B, et al. (2003) Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci 17: 2106–2118. 33. Aronica E, Gorter JA, Rozemuller AJ, Yankaya B, Troost D (2005) Interleukin-1 beta down-regulates the expression of metabotropic glutamate receptor 5 in cultured human astrocytes. J Neuroimmunol 160: 188–194. 34. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85. 35. Aronica E, Gorter JA, Redeker S, van Vliet EA, Ramkema M, et al. (2005) Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia 46: 849–857. 36. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095– 2147. 37. Gorter JA, Van Vliet E, Aronica E, Rauwerda H, Breit T, et al. (2006) Potential New Antiepileptogenic Targets Indicated by Microarray Analysis in a Rat Model for Temporal Lobe Epilepsy. Journal of Neuroscience 26: 11083–11110. 38. Aronica E, Gorter J (2007) Gene Expression Profile in Temporal Lobe Epilepsy. Neuroscientist 13: 1–9. 39. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, et al. (2009) MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132: 3342–3352. 40. Boer K, Spliet WG, van Rijen PC, Redeker S, Troost D, et al. (2006) Evidence of activated microglia in focal cortical dysplasia. J of Neuroimmunol 173: 188– 195. 41. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, et al. (2006) The IL- 1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 24: 128–143. 42. Aronica E, Boer K, van Vliet EA, Baayen JC, Redeker S, et al. (2007) Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26: 497–511. 43. Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, et al. (2010) Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51: 1763–1773. 44. Jung M, Schaefer A, Steiner I, Kempkensteffen C, Stephan C, et al. (2010) Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clinical Chem 56: 998–1006. miR-146a and Astrocyte Inflammatory Response 45. Boer K, Jansen K, Nellist M, Redeker M, van den Ouweland AMW, et al. (2008) Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy res 78: 7–21. 46. Yasin SA, Latak K, Becherini F, Ganapathi A, Mille K, et al. (2010) Balloon cells in human cortical dysplasia and tuberous sclerosis: isolation of a pathological progenitor-like cell. Acta Neuropathol 120(1):85–96. 47. Mei J, Bachoo R, Zhang CL (2011) MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cel Biol 31: 3584–3592. 48. Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kappaB-sensitive micro RNA-146a- mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283: 31315–31322. 49. Ravizza T, Redeker S, Spliet WGM, van Rijen PC, Troost D, et al. (2005) Expression and cellular distribution of interleukin-1 beta and the interleukin-1 receptor type 1 in focal cortical dysplasia and glioneuronal tumors. Epilepsia 46: 274; 273.003. 50. Hou J, Wang P, Lin L, Liu X, Ma F, et al. (2009) MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J immunol 183: 2150–2158. 51. Bartfai T, Sanchez-Alavez M, Andell-Jonsson S, Schultzberg M, Vezzani A, et al. (2007) Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma. Ann NY Acad Sci 1113: 173–177. 52. Aronica E, Ravizza T, Zurolo E, Vezzani V (in press) Astrocyte immune responses in epilepsy. GLIA. 53. Aronica E, Gorter JA, Rozemuller AJ, Yankaya B, Troost D (2005) Activation of metabotropic glutamate receptor 3 enhances interleukin (IL)-1beta-stimulated release of IL-6 in cultured human astrocytes. Neuroscience 130: 927–933. 54. Aloisi F, Borsellino G, Samoggia P, Testa U, Chelucci C, et al. (1992) Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J Neurosci Res 32: 494–506. 55. Sato T, Liu X, Nelson A, Nakanishi M, Kanaji N, et al. (2010) Reduced miR- 146a increases prostaglandin Ein chronic obstructive pulmonary disease fibroblasts. American journal of respiratory and critical care medicine 182: 1020–1029. 56. Li X, Gibson G, Kim JS, Kroin J, Xu S, et al. (2011) MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene 480: 34–41. 57. Whichard ZL, Motter AE, Stein PJ, Corey SJ (2011) Slowly produced microRNAs control protein levels. The Journal of biological chemistry 286: 4742–4748. PLOS ONE | www.plosone.org 13 September 2012 | Volume 7 | Issue 9 | e44789